Regulatory
Cori Gray, PharmD, Catherine E. Cooke, PharmD, MS (PHSR), BCPS, PAHM, Nicole Brandt, PharmD, MBA, BCPP, BCGP, FASCP
Cori Gray, PharmD; Catherine E. Cooke, PharmD, MS (PHSR), BCPS, PAHM; Nicole Brandt, PharmD,
MBA, BCPP, BCGP, FASCP
Successes and Challenges of the Medicare Part D MTM Program
Jack E. Fincham, PhD, RPh
Xiaomeng Yue, BPharm, MS; Jeff Jianfei Guo, BPharm, MS, PhD; Patricia R. Wigle, PharmD
The Importance and Benefits of Smoking-Cessation Therapy
Jack E. Fincham, PhD, RPh
Sergio I. Prada, MPA, PhD
Is the Federal Drug Utilization Review Requirement Just Red Tape or an Enlightened State of Flexibility?
Michael Kleinrock
Health Plan Subsidies, Prescription Drugs, and Cost
Implementing Payment Reform in Oncology: Benefits and Challenges
Alan L. Shields, PhD, Yanni Hao, PhD, Meaghan Krohe, PhD, Andrew Yaworsky, Iyar Mazar, MA, Catherine Foley, MPH, MA, Faisal Mehmed, MD, Denise Globe, PhD
Patient-Reported Outcomes in Oncology: Challenges and Opportunities for All Stakeholders
Junling Wang, PhD, Ya-Chen Tina Shih, PhD, Yolanda Qin, Theo Young, BS, Zachary Thomas, MS, MBA, Christina A. Spivey, PhD, David K. Solomon, BSc, PharmD, Marie Chisholm-Burns, PharmD, MPH, MBA, FCCP, FASHP, J. Warren Salmon, PhD